These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 6129465)

  • 21. [Membranous nephropathy caused by D-penicillamine].
    Prieto Carles C; Gutiérrez Millet V; Barrientos A; Bello I; Gómez Tierno A; Navas JJ; Rodicio JL
    Med Clin (Barc); 1982 Sep 1-15; 79(4):164-7. PubMed ID: 7144290
    [No Abstract]   [Full Text] [Related]  

  • 22. Coexistent membranous nephropathy and ANCA-positive crescentic glomerulonephritis in association with penicillamine.
    Mathieson PW; Peat DS; Short A; Watts RA
    Nephrol Dial Transplant; 1996 May; 11(5):863-6. PubMed ID: 8671912
    [No Abstract]   [Full Text] [Related]  

  • 23. Lichenoid lesions of the oral mucosa in rheumatoid arthritis patients treated with penicillamine.
    Blasberg B; Dorey JL; Stein HB; Chalmers A; Conklin RJ
    J Rheumatol; 1984 Jun; 11(3):348-51. PubMed ID: 6737375
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Toxicity of D-penicillamine in rheumatoid arthritis.
    O'Brien WM
    Ann Intern Med; 1980 Jan; 92(1):120-2. PubMed ID: 7350856
    [No Abstract]   [Full Text] [Related]  

  • 25. Penicillamine, its metabolism and therapeutic applications: a review.
    Crawhall JC; Lecavalier D; Ryan P
    Biopharm Drug Dispos; 1979; 1(2):73-95. PubMed ID: 399737
    [No Abstract]   [Full Text] [Related]  

  • 26. [Penicillamine-induced glomerulonephritis].
    Koall W; Mampel E
    Z Urol Nephrol; 1977 Jan; 70(1):13-7. PubMed ID: 848141
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The side effects of penicillamine therapy in rheumatoid arthritis.
    Huskisson EC
    J Rheumatol Suppl; 1981; 7():146-8. PubMed ID: 6939876
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Immune complex nephritis with nephrotic syndrome following D-penicillamine therapy].
    Hallauer W; Gärtner HV; Kronenberg KH; Manz G
    Schweiz Med Wochenschr; 1974 Mar; 104(12):434-8. PubMed ID: 4820540
    [No Abstract]   [Full Text] [Related]  

  • 29. Deficient sulphoxidation status and D-penicillamine toxicity.
    Panayi GS; Huston G; Shah RR; Mitchell SC; Idle JR; Smith RL; Waring RH
    Lancet; 1983 Feb; 1(8321):414. PubMed ID: 6130402
    [No Abstract]   [Full Text] [Related]  

  • 30. Penicillamine and other remittive agents in rheumatoid arthritis: comparisons and interaction.
    Stein HB; Ruedy J; Atkins CJ; Offer RC
    Clin Invest Med; 1984; 7(1):59-63. PubMed ID: 6723126
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The relationship between D-penicillamine--induced proteinuria and prior gold nephropathy.
    Billingsley LM; Stevens MB
    Johns Hopkins Med J; 1981 Feb; 148(2):64-7. PubMed ID: 7206401
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Studies on the metabolism of D-penicillamine and its interaction with probenecid in cystinuria and rheumatoid arthritis.
    Yu TF; Roboz J; Johnson S; Kaung C
    J Rheumatol; 1984 Aug; 11(4):467-70. PubMed ID: 6481720
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Proteinuria in D-penicillamine-treated rheumatoid arthritis.
    Crawhall JC
    J Rheumatol Suppl; 1981; 7():161-3. PubMed ID: 6939879
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thrombotic thrombocytopenic purpura during penicillamine therapy in rheumatoid arthritis.
    Trice JM; Pinals RS; Plitman GI
    Arch Intern Med; 1983 Jul; 143(7):1487-8. PubMed ID: 6683487
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Penicillamine nephropathy in rheumatoid arthritis. A clinical, pathological and immunological study.
    Bacon PA; Tribe CR; Mackenzie JC; Verrier-Jones J; Cumming RH; Amer B
    Q J Med; 1976 Oct; 45(180):661-84. PubMed ID: 1005658
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Membranous nephropathy in rheumatoid arthritis.
    Figueroa JE; Waxman J
    South Med J; 1982 Apr; 75(4):480-2. PubMed ID: 7071645
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Penicillamine nephropathy.
    Ross JH; McGinty F; Brewer DG
    Nephron; 1980; 26(4):184-6. PubMed ID: 7432580
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The metabolism and pharmacology of D-penicillamine in man.
    Perrett D
    J Rheumatol Suppl; 1981; 7():41-50. PubMed ID: 7014876
    [TBL] [Abstract][Full Text] [Related]  

  • 39. D-penicillamine in patients with rheumatoid arthritis. Serum levels, pharmacokinetic aspects, and correlation with clinical course and side effects.
    Muijsers AO; van de Stadt RJ; Henrichs AM; Ament HJ; van der Korst JK
    Arthritis Rheum; 1984 Dec; 27(12):1362-9. PubMed ID: 6508861
    [TBL] [Abstract][Full Text] [Related]  

  • 40. D-Penicillamine induced toxicity in rheumatoid arthritis: the role of sulphoxidation status and HLA-DR3.
    Emery P; Panayi GS; Huston G; Welsh KI; Mitchell SC; Shah RR; Idle JR; Smith RL; Waring RH
    J Rheumatol; 1984 Oct; 11(5):626-32. PubMed ID: 6334741
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.